Home » Topics » BioWorld Science

BioWorld Science
RSS

Immunomedics submits BLA for sacituzumab govitecan for metastatic TNBC

May 22, 2018

Merck & Co.'s rVSV-ZEBOV Ebola vaccine deployed in Democratic Republic of Congo

May 22, 2018

FDA accepts NDA for Rifamycin SV MMX

May 22, 2018

KRAS-G12C inhibitors reveal new approach to undruggable targets

May 22, 2018

FDA approves Lokelma for hyperkalemia

May 22, 2018

New anticancer adaptive cell therapy approach as cancer immunotherapeutic shows promise

May 22, 2018

Lundbeck begins clinical development with PDE1 inhibitor Lu-AF-76432

May 22, 2018

Prolia approved in U.S. for glucocorticoid-induced osteoporosis

May 22, 2018

FDA awards breakthrough therapy and fast track designations to Harmony's pitolisant

May 22, 2018

European Commission approves Juluca for HIV-1

May 22, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...